-
Product Insights
Elizabeth Pelligra Solar PV Park
Elizabeth Pelligra Solar PV Park is a solar PV project located in South Australia, Australia. The project is owned and being developed by CEP Energy Pty Ltd. The project is at the permitting stage. Empower your strategies with our Elizabeth Pelligra Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
Mount Olive Solar PV Park I
Mount Olive Solar PV Park I is a solar PV project located in New Jersey, United States. The project is owned by NJR Clean Energy Ventures Corp and was developed by CEP Renewables LLC. The project came online in 2022. Empower your strategies with our Mount Olive Solar PV Park I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Hughesville Paper Mill Solar PV Park
Hughesville Paper Mill Solar PV Park is a solar PV project located in New Jersey, United States. The project is owned and being developed by CEP Renewables LLC. The project is at the permitting stage. Empower your strategies with our Hughesville Paper Mill Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RXDX-105 in Lung Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RXDX-105 in Lung Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RXDX-105 in Lung Adenocarcinoma Drug Details: RXDX-105 (CEP-32496) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RXDX-105 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RXDX-105 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RXDX-105 in Solid Tumor Drug Details:RXDX-105 (CEP-32496) is under development for the treatment...
-
Product Insights
CEP Eng – Kurri Kurri Battery Facility – New South Wales
Equip yourself with the essential tools needed to make informed and profitable decisions with our CEP Eng - Kurri Kurri Battery Facility - New South Wales report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
CEP Renews – Mount Olive Solar PV Park I 25.6 MW – New Jersey
Equip yourself with the essential tools needed to make informed and profitable decisions with our CEP Renews - Mount Olive Solar PV Park I 25.6 MW - New Jersey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Company Profile
Venus Medtech Hangzhou Inc – Company Profile
Venus Medtech HangZhou Inc (Venus MedTech) is a medical device company that focus on development and commercialization of transcatheter heart valve products for structural heart diseases. The company's product portfolio includes venusA- valve, venusP- valve, V8/TAV8, and TriGUARD3 CEP device. It's products find applications in transcatheter aortic valve replacement system, anti-embolic distal brain protection device, TAV8 balloon dilatation catheter, transcatheter prosthetic pulmonary valve system, TMVr&TTVr mitral and tricuspid valve repair and replacement, RDN therapy, hypertrophic cardiomyopathy, transcatheter pulmonary valve replacement,...
Add to Basket -
Product Insights
Venus Medtech Hangzhou Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Venus Medtech Hangzhou Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Venus Medtech HangZhou Inc (Venus MedTech) is a medical device company that focus on development and commercialization of transcatheter heart valve products for structural heart diseases. The company's product portfolio includes venusA- valve, venusP- valve, V8/TAV8, and TriGUARD3 CEP device. It's products find applications in transcatheter aortic valve replacement system, anti-embolic distal brain protection device, TAV8 balloon dilatation...